- Home
- SBLK vs BCRX Comparison
SBLK vs BCRX Comparison
Compare SBLK & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SBLK | BCRX |
|---|---|---|
| Founded | 2006 | 1986 |
| Country | Greece | United States |
| Employees | 301 | N/A |
| Industry | Marine Transportation | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.1B |
| IPO Year | 2007 | 1995 |
Fundamental Metrics
Financial Performance| Metric | SBLK | BCRX |
|---|---|---|
| Price | N/A | $9.71 |
| Analyst Decision | | Strong Buy |
| Analyst Count | | 11 |
| Target Price | N/A | $20.82 |
| AVG Volume (30 Days) | N/A | 5.3M |
| Earning Date | 03-22-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | 381.40 |
| EPS | N/A | 1.21 |
| Revenue | N/A | $25,186,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $12.55 |
| P/E Ratio | N/A | $8.17 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | N/A | $6.00 |
| 52 Week High | N/A | $11.31 |
Technical Indicators
Market Signals| Indicator | SBLK | BCRX |
|---|---|---|
| Relative Strength Index (RSI) | 40.83 | 73.15 |
| Support Level | $21.64 | $7.99 |
| Resistance Level | $27.20 | N/A |
| Average True Range (ATR) | 0.80 | 0.45 |
| MACD | -0.31 | 0.09 |
| Stochastic Oscillator | 14.42 | 73.04 |
Price Performance
Historical ComparisonAbout SBLK Star Bulk Carriers Corp.
Star Bulk Carriers Corp provides seaborne transportation solutions in the dry bulk sector. The company owns and operates dry bulk carrier vessels, which are used to transport bulk, such as iron ore, coal, grains, bauxite, fertilizers, and steel products. It owns a fleet of vessels that consists of Newcastlemax, Capesize, Post Panamax, Kamsarmax, Panamax, Ultramax, and Supramax. It generates revenues through the voyages it carries out.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.